This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Lixue Fan: Innovator in Anti-Tumor Compounds
Introduction
Lixue Fan is a notable inventor based in Shijiazhuang, China. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with anti-tumor activity. Her innovative work focuses on creating novel structures that can lead to new therapeutic options for cancer treatment.
Latest Patent Applications
Lixue Fan has filed several patent applications that showcase her research and findings. One of her latest applications is titled "HETEROCYCLIC COMPOUND HAVING ANTI-TUMOR ACTIVITY AND USE THEREOF." This application describes a class of compounds with a tri-heterocyclic structure, which provides a new direction for the development of SOS1 inhibitor drugs. The compounds demonstrate a strong inhibition effect on SOS1 and show promise for preventing and treating SOS1-mediated diseases. Additionally, they exhibit significant inhibitory activity on NCI-H358 cell proliferation. The application also includes a specific synthesis method that is simple, convenient, and beneficial for large-scale industrial production.
Another recent application is "A CLASS OF FUSED RING COMPOUNDS, AND PREPARATION AND USE THEREOF." This invention relates to a class of fused ring compounds that significantly inhibit ATM kinase activity. The compounds have good selectivity for the ATM target and are intended for pharmaceutical use in treating cancer.
Conclusion
Lixue Fan is an innovative inventor whose work in developing anti-tumor compounds holds great potential for advancing cancer treatment. Her latest patent applications reflect her commitment to creating effective therapeutic options.